Deerfield Management as of June 30, 2016
Portfolio Holdings for Deerfield Management
Deerfield Management holds 106 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 8.9 | $226M | 14M | 16.47 | |
| NxStage Medical | 3.8 | $98M | 4.5M | 21.68 | |
| Gw Pharmaceuticals Plc ads | 3.6 | $91M | 992k | 91.57 | |
| Portola Pharmaceuticals | 3.4 | $87M | 3.7M | 23.60 | |
| Avexis | 3.3 | $85M | 2.2M | 38.02 | |
| Adeptus Health Inc-class A | 3.2 | $83M | 1.6M | 51.66 | |
| XenoPort | 3.2 | $82M | 12M | 7.04 | |
| Horizon Pharma Plc convertible security | 3.0 | $75M | 83M | 0.91 | |
| Healthways Inc note 1.500% 7/0 | 2.8 | $72M | 77M | 0.94 | |
| Vanda Pharmaceuticals (VNDA) | 2.6 | $67M | 6.0M | 11.19 | |
| Mylan Nv | 2.3 | $58M | 1.3M | 43.24 | |
| Dbv Technologies S A | 2.2 | $57M | 1.7M | 32.62 | |
| Xencor (XNCR) | 2.2 | $56M | 2.9M | 18.99 | |
| Walgreen Boots Alliance | 2.0 | $51M | 612k | 83.27 | |
| Aac Holdings | 1.9 | $49M | 2.1M | 22.82 | |
| Aetna | 1.8 | $45M | 366k | 122.13 | |
| Aerie Pharmaceuticals | 1.7 | $44M | 2.5M | 17.60 | |
| Trn 4% 04/01/45 | 1.7 | $44M | 48M | 0.92 | |
| Flamel Technologies | 1.7 | $44M | 4.1M | 10.74 | |
| Editas Medicine (EDIT) | 1.6 | $42M | 1.7M | 24.40 | |
| DaVita (DVA) | 1.6 | $41M | 525k | 77.32 | |
| Heartware Intl Inc note 3.500%12/1 | 1.6 | $40M | 40M | 0.99 | |
| Array Biopharma Inc note 3.000% 6/0 | 1.5 | $38M | 45M | 0.84 | |
| Syros Pharmaceuticals | 1.5 | $38M | 2.1M | 18.15 | |
| Endologix Inc note 2.250%12/1 | 1.5 | $38M | 41M | 0.92 | |
| eHealth (EHTH) | 1.4 | $37M | 2.6M | 14.02 | |
| Wright Med Group Inc note 2.000% 2/1 | 1.4 | $37M | 40M | 0.92 | |
| Zeltiq Aesthetics | 1.4 | $35M | 1.3M | 27.33 | |
| Universal American | 1.3 | $33M | 4.3M | 7.58 | |
| Relypsa | 1.2 | $31M | 1.7M | 18.50 | |
| Heartware Intl Inc note 1.750%12/1 | 1.2 | $30M | 30M | 0.99 | |
| Array BioPharma | 1.2 | $30M | 8.4M | 3.56 | |
| Healthways | 1.1 | $29M | 2.5M | 11.55 | |
| Humana (HUM) | 1.1 | $29M | 160k | 179.88 | |
| Glaukos (GKOS) | 1.1 | $29M | 984k | 29.16 | |
| Global Blood Therapeutics In | 1.1 | $29M | 1.7M | 16.59 | |
| Acorda Therapeutics | 1.0 | $26M | 1.0M | 25.50 | |
| Galapagos Nv- (GLPG) | 1.0 | $25M | 458k | 55.47 | |
| Axogen (AXGN) | 0.9 | $23M | 3.4M | 6.88 | |
| CIGNA Corporation | 0.9 | $22M | 171k | 127.99 | |
| Molina Healthcare (MOH) | 0.8 | $22M | 436k | 49.90 | |
| Lannett Company | 0.8 | $21M | 896k | 23.79 | |
| Rite Aid Corporation | 0.8 | $20M | 2.6M | 7.49 | |
| Cotiviti Hldgs | 0.8 | $19M | 900k | 21.13 | |
| Spark Therapeutics | 0.7 | $19M | 368k | 51.13 | |
| Alnylam Pharmaceuticals (ALNY) | 0.7 | $19M | 336k | 55.49 | |
| Five Prime Therapeutics | 0.7 | $19M | 448k | 41.35 | |
| Zafgen | 0.7 | $18M | 3.1M | 5.99 | |
| Nivalis Therapeutics | 0.7 | $17M | 3.7M | 4.60 | |
| Fluidigm Corporation convertible cor | 0.7 | $17M | 28M | 0.60 | |
| Akari Therapeutics | 0.6 | $16M | 1.2M | 13.49 | |
| Bluebird Bio | 0.6 | $15M | 338k | 43.29 | |
| Select Medical Holdings Corporation (SEM) | 0.6 | $14M | 1.3M | 10.87 | |
| Invuity | 0.5 | $13M | 1.3M | 9.53 | |
| Proteon Therapeutics | 0.5 | $13M | 1.6M | 8.03 | |
| Spectranetics Corp mtnf 2.625% 6/0 | 0.4 | $11M | 13M | 0.88 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $9.6M | 943k | 10.21 | |
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $9.4M | 1.2M | 8.00 | |
| Nanostring Technologies (NSTGQ) | 0.3 | $8.5M | 675k | 12.60 | |
| Foamix Pharmaceuticals | 0.3 | $8.1M | 1.3M | 6.35 | |
| BioScrip | 0.3 | $7.6M | 3.0M | 2.55 | |
| Incyte Corporation (INCY) | 0.3 | $7.3M | 91k | 79.98 | |
| Alimera Sciences | 0.3 | $7.2M | 5.9M | 1.23 | |
| Amag Pharmaceuticals Inc note 2.500% 2/1 | 0.3 | $7.2M | 6.5M | 1.10 | |
| Epizyme | 0.2 | $6.4M | 622k | 10.24 | |
| Essa Pharma | 0.2 | $6.4M | 2.2M | 2.95 | |
| CAS Medical Systems | 0.2 | $5.9M | 3.2M | 1.84 | |
| Loxo Oncology | 0.2 | $5.8M | 251k | 23.18 | |
| Endochoice Hldgs | 0.2 | $5.9M | 1.2M | 4.90 | |
| Kempharm | 0.2 | $5.7M | 1.4M | 3.98 | |
| Aralez Pharmaceuticals | 0.2 | $5.4M | 1.6M | 3.30 | |
| Rigel Pharmaceuticals | 0.2 | $5.2M | 2.3M | 2.23 | |
| Alcobra | 0.2 | $4.8M | 1.1M | 4.49 | |
| Myokardia | 0.2 | $4.6M | 375k | 12.40 | |
| pSivida | 0.2 | $4.2M | 1.5M | 2.83 | |
| Steadymed | 0.2 | $4.4M | 1.3M | 3.27 | |
| Neos Therapeutics | 0.2 | $4.3M | 458k | 9.28 | |
| Oxford Immunotec Global | 0.2 | $4.2M | 465k | 9.00 | |
| Scynexis | 0.1 | $3.8M | 1.8M | 2.17 | |
| Pronai Therapeutics | 0.1 | $3.2M | 1.6M | 1.99 | |
| Genocea Biosciences | 0.1 | $2.8M | 687k | 4.10 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $2.6M | 1.9M | 1.33 | |
| Voyager Therapeutics (VYGR) | 0.1 | $2.6M | 235k | 10.99 | |
| Clovis Oncology | 0.1 | $2.3M | 170k | 13.72 | |
| Ardelyx (ARDX) | 0.1 | $2.4M | 275k | 8.73 | |
| Catabasis Pharmaceuticals | 0.1 | $2.4M | 644k | 3.70 | |
| Alphatec Holdings | 0.1 | $1.7M | 5.0M | 0.35 | |
| Pacira Pharmaceuticals (PCRX) | 0.1 | $1.7M | 50k | 33.74 | |
| Agile Therapeutics | 0.1 | $1.9M | 250k | 7.61 | |
| Acura Pharmaceuticals (ACUR) | 0.1 | $1.9M | 1.0M | 1.85 | |
| Innocoll Hldgs | 0.1 | $1.7M | 303k | 5.51 | |
| Threshold Pharmaceuticals | 0.1 | $1.7M | 2.6M | 0.64 | |
| Aldeyra Therapeutics (ALDX) | 0.1 | $1.5M | 268k | 5.69 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $1.5M | 172k | 8.98 | |
| Paratek Pharmaceuticals | 0.1 | $1.4M | 100k | 13.91 | |
| Ocera Therapeutics | 0.0 | $1.1M | 573k | 1.90 | |
| Corsicanto Ltd conv bnd | 0.0 | $1.0M | 1.0M | 1.02 | |
| Streamline Health Solutions | 0.0 | $796k | 663k | 1.20 | |
| Egalet | 0.0 | $805k | 162k | 4.96 | |
| Cynapsus Therapeutics | 0.0 | $818k | 49k | 16.75 | |
| Pacific Biosciences of California (PACB) | 0.0 | $444k | 63k | 7.04 | |
| Endo International | 0.0 | $468k | 30k | 15.60 | |
| Caredx (CDNA) | 0.0 | $221k | 51k | 4.32 | |
| Tracon Pharmaceuticals | 0.0 | $296k | 68k | 4.38 | |
| Rennova Health | 0.0 | $111k | 176k | 0.63 | |
| Rennova Health Inc. Warrants *w | 0.0 | $26k | 645k | 0.04 |
